ASX
Paradigm Biopharmaceuticals Limited
PAR:ASX•Healthcare
Sensitive ASX Announcement
Paradigm OA Phase 2b Clinical Trial over 80% Recruited
Published: 17/05/18, 08:56am (AEST)•3 pages